April 30, 2023
Texas CARES researchers analyzed COVID-19 variant symptoms among Texas CARES participants ages 5-19. Their findings were published in Children by MDPI. Download a summary of the article by clicking here.
February 7, 2023
Breakthrough COVID-19 infections after vaccination occurred in 7.5% of Texans surveyed, and higher odds were associated with Hispanic ethnicity, larger household size, rural versus urban living, type of vaccination, and multiple comorbidities, according to findings from UTHealth Houston School of Public Health, published Feb. 2 in the Journal of Infectious Diseases.
February 2, 2023
Texas CARES researchers analyzed breakthrough COVID-19 infections after vaccination among Texas CARES participants. Their findings were published in The Journal of Infectious Diseases.
November 1, 2022
The National Geographic cited the Texas CARES article “Comparison of Persistent Symptoms Following SARS-CoV-2 Infection by Antibody Status in Nonhospitalized Children and Adolescents” in its recent look at long COVID in children around the world.
September 12, 2022
Public health and safety strategies are only as effective as the information that guides them. Researchers and scientists at UTHealth Houston and the Texas Department of State Health Services (DSHS) developed a more accurate way to estimate the percentage of community members with some level of protection from antibodies developed in response to COVID-19 infection or vaccination. These findings could help shape public pandemic preparedness both now and in the future.
September 9, 2022
Texas CARES researchers determined a way to estimate antibodies to COVID-19 infections and COVID-19 vaccinations in people living in a large region. The findings were published in PLOS ONE.
August 8, 2022
While research has revealed that children and adults hospitalized with COVID-19 are more susceptible to developing long COVID symptoms, a new study by researchers at UTHealth Houston found that children infected with COVID-19, but not hospitalized, still experienced long COVID symptoms up to three months past infection.
August 1, 2022
The Texas CARES team examined the presence of persistent COVID symptoms — or long COVID — in children by COVID-19 antibody status between October 2020 and May 2022. The article was published in The Pediatric Infectious Disease Journal. Download a summary of the article by clicking here.
May 31, 2022
Adults infected with COVID-19 develop circulating antibodies that last for nearly 500 days, according to a new study led by researchers at UTHealth School of Public Health.
May 27, 2022
Texas CARES researchers examined how long antibodies from a COVID-19 infection lasted in participants ages 5-19 years old. The findings were published in Pediatrics. Download a summary of the article by clicking here.
